HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cilastatin and relebactam imipenem

Also Known As:

imipenem, cilastatin and relebactam; Recarbrio

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Pharmaceutical Preparations
- Drug Combinations: 5337
  - cilastatin and relebactam imipenem: 3
Organic Chemicals: 133
Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Monounsaturated Fatty Acids: 676
      - Cilastatin: 128
        cilastatin and relebactam imipenem: 3
Heterocyclic Compounds: 198
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - Azabicyclo Compounds
      - cilastatin and relebactam imipenem: 3
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Carbapenems: 4837
        Thienamycins: 1
        Imipenem: 1684
        cilastatin and relebactam imipenem: 3

Experts

1.	Chopra, S: 1 article (04/2020)
2.	Dasgupta, A: 1 article (04/2020)
3.	Thakare, R: 1 article (04/2020)
4.	Chen, Qinghao: 1 article (01/2020)
5.	Chung, John Y L: 1 article (01/2020)
6.	Dumas, Aaron: 1 article (01/2020)
7.	Gudipati, Venugopal: 1 article (01/2020)
8.	Lam, Yu-Hong: 1 article (01/2020)
9.	Liu, Yizhou: 1 article (01/2020)
10.	Meng, Dongfang: 1 article (01/2020)

Related Diseases

1.	Intraabdominal Infections 12/31/2019 - "Two combinatorial strategies were approved for complicated urinary tract infections, complicated intra-abdominal infections (imipenem, cilastatin and relebactam) and lung tuberculosis (pretomanid in combination with bedaquiline and linezolid). "
2.	Urinary Tract Infections (Urinary Tract Infection) 12/31/2019 - "Two combinatorial strategies were approved for complicated urinary tract infections, complicated intra-abdominal infections (imipenem, cilastatin and relebactam) and lung tuberculosis (pretomanid in combination with bedaquiline and linezolid). "
3.	Tuberculosis (Tuberculoses) 12/31/2019 - "Two combinatorial strategies were approved for complicated urinary tract infections, complicated intra-abdominal infections (imipenem, cilastatin and relebactam) and lung tuberculosis (pretomanid in combination with bedaquiline and linezolid). "
4.	Communicable Diseases (Infectious Diseases) 04/01/2020 - "The combination (Recarbrio) has been designated as a qualified infectious disease product (QIDP) and obtained FDA approval in 2019 for the treatment of cUTI and cIAI caused by susceptible Gram-negative microorganisms in adult patients with limited or no alternative treatment options. "
5.	Bacterial Infections (Bacterial Infection) 01/01/2020 - "Relebactam, a potent β-lactamase inhibitor, in combination with Primaxin is an FDA-approved (Recarbrio) treatment for serious and antibiotic-resistant bacterial infections. "

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	Imipenem Drug Combination Cilastatin (Primaxin)
3.	Linezolid (Zyvox)
4.	relebactam
5.	bedaquiline (R207910)
6.	pretomanid